期刊
REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY
卷 32, 期 6, 页码 871-882出版社
SPRINGERNATURE
DOI: 10.1007/s43450-022-00297-z
关键词
Nanocarrier; Nanotechnology; Xanthone; Natural compounds; Pharmacokinetics; Bioavailability
资金
- Science, Technology & Innovation Funding Authority (STDF)
- The Egyptian Knowledge Bank (EKB)
Nutraceuticals have shown valuable contributions in disease treatment, but their efficacy is limited by poor solubility. Delivery carriers can overcome these limitations and improve their pharmacological effects.
Nutraceuticals have recently gained interest owing to their valuable contribution in the treatment of several diseases, with high safety margin and low incidence of side effects. However, their efficacy is limited by some challenges, namely poor solubility, low permeability, and, consequently, low bioavailability. Delivery carriers have proven that they can overcome almost all the aforementioned limitations, leading to improvement in the pharmacological efficacy of nutraceuticals. Among the promising nutraceuticals that have currently evoked considerable interest is mangiferin from mango tree, which is a polyphenol exhibiting many favorable pharmacological actions, but unfortunately suffers from poor aqueous solubility and other limitations that lower its bioavailability and halter its efficacy. This review summarizes the pharmacological actions of mangiferin and provides an insight on how delivery carriers for mangiferin (lipidic, vesicular, polymeric, inorganic, and protein nanoparticles, as well as complexes) can overcome its pharmaceutical challenges, hence reflecting on its improved therapeutic effects in treatment of different diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据